Kathleen Page is an Endocrinology/Metabolic physician. ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1520 San Pablo St
Suite 1000
Los Angeles, CA 900335310
Telephone
323-442-2804Registry record last updated 25 Jun 2014.
Clinical trials
- Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities
Sponsor: Johns Hopkins University
- Leveraging mHealth and Peers to Engage African- Americans and Latinxs in HIV Care (LEAN)
Sponsor: Johns Hopkins University
- Building on Needle Exchange to Optimize Prevention & Treatment
Sponsor: Johns Hopkins University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20251 payment
- Travere Therapeutics, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
96.9%GLP-1 receptor agonist28.9%Ozempic64%Mounjaro19%Trulicity17%Part D<11 patientsSGLT2 inhibitor27.9%Farxiga53%Jardiance47%Part D≥16 patients+ 3 more classes in this area
Nervous system
3.1%SSRI3.1%Escitalopram Oxalate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
10 NIH research awards on record, funded 1989–2026 per NIH RePORTER. The latest:
- The Role of Gut-Brain Pathways on Childhood Obesity and Type 2 Diabetes Development
University of Southern California
FY2026$845,922R01DK145940 - Effects of prenatal exposures to maternal obesity and gestational diabetes on metabolic decline from childhood to adolescence and underlying neurobiological pathways
University of Southern California
FY2026$801,852R01DK134079 - Longitudinal Evaluation of Neurocognitive Complications in Pediatric Type 1 Diabetes Across Multi-Ethnic Groups—Exploring Risk and Protective Factors
University of Southern California
FY2026$602,903U01DK140786
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”